Newsroom

Industry News

11 Jan

Grow Solutions Holdings, Inc. Issues Special Letter to Shareholders

DENVER, CO / ACCESSWIRE / January 11, 2017 / Grow Solutions Holdings, Inc. (GRSO) (the “Company” or “Grow Solutions”), a company involved in the development and distribution of high demand products for cultivation, processing and consumption of legal cannabis, today issued the following special letter to shareholders from its...

Read more

10 Jan

Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference

NEW YORK, Jan. 10, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that Sandesh Seth, Actinium’s Executive Chairman, will be presenting at the 9th Annual Biotech Showcase conference being...

Read more

10 Jan

Protea In Marketing Partnership with MatTek Corp.

MORGANTOWN, W.Va., Jan. 10, 2017 (GLOBE NEWSWIRE) — Protea Biosciences Group, Inc. (PRGB) (“Protea”) announced today that the Company has entered into a co-marketing agreement with MatTek Corporation (“MatTek”), which allows Protea to include MatTek’s human cell based in vitro tissue models with Protea’s proprietary molecular imaging services. “By...

Read more

10 Jan

Onconova Therapeutics, Inc. Discusses Target Indications and Clinical Development in New SNNLive Video Interview on StockNewsNow.com

LOS ANGELES, Jan. 10, 2017 /PRNewswire/ — StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Ramesh Kumar, President & CEO of Onconova Therapeutics, Inc. (ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with primary focus on...

Read more

10 Jan

NEMUS Bioscience Announces Closing of $1,200,000 Preferred Stock Financing

COSTA MESA, CA / ACCESSWIRE / January 10, 2017 / NEMUS Bioscience, Inc. (NMUS) today announced the closing of its Preferred Stock financing for gross proceeds of $1,200,000. Roth Capital Partners acted as the exclusive placement agent for the transaction. ABOUT NEMUS BIOSCIENCE, INC. The Company is a biopharmaceutical...

Read more

6 Jan

MySize Inc. Launches SizeUp “Measurement from the Air” App at CES 17

AIRPORT CITY, Israel, Jan. 10, 2017 /PRNewswire/ — @CES 17 and ShowStoppers @ CES 17 — MySize Inc. (the “Company”) (NASDAQ: MYSZ;TASE: MYSZ), developer of unique measurement technology applications for Smartphones, announced today, during a press conference at CES 17, the official launch of its SizeUp DIY “measurement from the air”...

Read more

6 Jan

Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical

TORONTO, Jan. 06, 2017 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (IPCI) (TSX:I)  (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs today announced that its United States (“U.S.”) marketing partner, Par Pharmaceutical (“Par”), has...

Read more

5 Jan

MTBC Names Office Manager of the Year for 2016

SOMERSET, NJ–(Marketwired – Jan 5, 2017) – MTBC ( NASDAQ : MTBC ) ( NASDAQ : MTBCP ), a leading provider of proprietary web-based electronic health records, is proud to announce Baqar Naqvi from Progressive Medical Care, LLC as the Office Manager of The Year for 2016. Progressive Medical...

Read more

Page 10 of 216« First...89101112...203040...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address